Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardization.
Fareed
J
J
Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153.
Walenga
J M
JM
Hoppensteadt
D
D
Racanelli
A
A
Coyne
E
E
D000818:Animals; D000990:Antithrombin III / Q000378:metabolism; D001682:Biological Availability; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors; D002417:Cattle; D004341:Drug Evaluation; D004347:Drug Interactions; D004348:Drug Labeling; D006493:Heparin / Q000032:analysis / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000302:isolation & purification / Q000493:pharmacokinetics / Q000494:pharmacology / Q000592:standards; D015394:Molecular Structure; D008970:Molecular Weight; D012015:Reference Standards; D012307:Risk Factors; D013552:Swine
D001779:Blood Coagulation Factors; D006495:Heparin, Low-Molecular-Weight; D000990:Antithrombin III; D006493:Heparin